| Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants MR Abrahams, JA Anderson, EE Giorgi, C Seoighe, K Mlisana, LH Ping, ... Journal of virology 83 (8), 3556-3567, 2009 | 500 | 2009 |
| Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape PL Moore, ES Gray, CK Wibmer, JN Bhiman, M Nonyane, DJ Sheward, ... Nature medicine 18 (11), 1688-1692, 2012 | 374 | 2012 |
| Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection PL Moore, N Ranchobe, BE Lambson, ES Gray, E Cave, MR Abrahams, ... PLoS pathogens 5 (9), e1000598, 2009 | 279 | 2009 |
| Vertical T cell immunodominance and epitope entropy determine HIV-1 escape MKP Liu, N Hawkins, AJ Ritchie, VV Ganusov, V Whale, S Brackenridge, ... The Journal of clinical investigation 123 (1), 2012 | 215 | 2012 |
| The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation MR Abrahams, SB Joseph, N Garrett, L Tyers, M Moeser, N Archin, ... Science translational medicine 11 (513), eaaw5589, 2019 | 187 | 2019 |
| Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 … LH Ping, SB Joseph, JA Anderson, MR Abrahams, JF Salazar-Gonzalez, ... Journal of virology 87 (13), 7218-7233, 2013 | 132 | 2013 |
| Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women L Roberts, JAS Passmore, K Mlisana, C Williamson, F Little, LM Bebell, ... Journal of Infectious Diseases 205 (2), 194-203, 2012 | 99 | 2012 |
| Antiviral activity of purified human breast milk mucin HH Habte, GJ Kotwal, ZE Lotz, MG Tyler, M Abrahams, J Rodriques, ... Neonatology 92 (2), 96-104, 2007 | 64 | 2007 |
| Growing poxviruses and determining virus titer GJ Kotwal, MR Abrahams Vaccinia virus and poxvirology: methods and protocols, 101-112, 2004 | 40 | 2004 |
| The Mtb-HIV Syndemic Interaction: Why Treating M. tuberculosis Infection May Be Crucial for HIV-1 Eradication R Waters, M Ndengane, MR Abrahams, CR Diedrich, RJ Wilkinson, ... Future virology 15 (2), 101-126, 2020 | 36 | 2020 |
| Addressing an HIV cure in LMIC SD Ismail, J Pankrac, E Ndashimye, JL Prodger, MR Abrahams, ... Retrovirology 18 (1), 21, 2021 | 34 | 2021 |
| Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cells C Riou, F Treurnicht, MR Abrahams, K Mlisana, MKP Liu, N Goonetilleke, ... The Journal of Immunology 189 (8), 3838-3847, 2012 | 34 | 2012 |
| Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure FK Treurnicht, C Seoighe, DP Martin, N Wood, MR Abrahams, ... Virology 396 (2), 213-225, 2010 | 32 | 2010 |
| CAPRISA 002 study PL Moore, N Ranchobe, BE Lambson, ES Gray, E Cave, MR Abrahams, ... NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI), 2009 | 28 | 2009 |
| Antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies constrain neutralizing antibody escape pathway D Mielke, G Bandawe, J Pollara, MR Abrahams, T Nyanhete, P Moore, ... Frontiers in Immunology 10, 2875, 2019 | 27 | 2019 |
| Case report: mechanisms of HIV elite control in two African women Y Moosa, RF Tanko, V Ramsuran, R Singh, M Madzivhandila, ... BMC infectious diseases 18, 1-7, 2018 | 24 | 2018 |
| The Vaccinia Virus N1L Protein Influences Cytokine Secretion in Vitro after Infection Z Zhang, MR ABRAHAMS, LA Hunt, J Suttles, W Marshall, DK LAHIRI, ... Annals of the New York Academy of Sciences 1056 (1), 69-86, 2005 | 24 | 2005 |
| Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression MR Abrahams, FK Treurnicht, NK Ngandu, SA Goodier, JC Marais, ... Aids 27 (4), 507-518, 2013 | 22 | 2013 |
| CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck Z Valley-Omar, S Sibeko, J Anderson, S Goodier, L Werner, L Arney, ... The Journal of infectious diseases 206 (1), 35-40, 2012 | 22 | 2012 |
| Replication capacity of viruses from acute infection drives HIV-1 disease progression P Selhorst, C Combrinck, N Ndabambi, SD Ismail, MR Abrahams, ... Journal of virology 91 (8), 10.1128/jvi. 01806-16, 2017 | 20 | 2017 |
